Acid Suppressive Drugs

Acid Suppressive Drugs

Histamine H2 receptor antagonists (H2RAs) suppress gastric acid production by blocking H2 receptors in parietal cells. Studies have shown that proton pump inhibitors (PPIs) are superior to H2RAs as a treatment for acid-related disorders, such as peptic ulcer disease (PUD) and gastroesophageal reflux...

Full description

Bibliographic Details
Main Author:	Cheol Min Shin
Format:	Article
Language:	English
Published:	Yong Chan Lee 2022-06-01
Series:	The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:	histamine h receptor antagonists potassium competitive acid blocker proton pump inhibitors
Online Access:	http://www.helicojournal.org/upload/pdf/kjhugr-2022-0016.pdf

Similar Items

Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01)

Vonoprazan - a new drug for inhibiting gastric acid secretion
by: Kacper Niewęgłowski, et al.
Published: (2022-08-01)

Impact of proton pump inhibitor management committee’s multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments
by: Lu Liu, et al.
Published: (2022-03-01)

History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs
by: Dong Han Yeom, et al.
Published: (2023-09-01)

Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients
by: Akiomi Yoshihisa, et al.
Published: (2017-05-01)

Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. <i>J. Clin. Med.</i> 2022, <i>11</i>, 5612
by: Ai-Hsien Li, et al.
Published: (2022-12-01)

Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies
by: Jiangbi Li, et al.
Published: (2021-08-01)

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs
by: Amanda Kuhl, et al.
Published: (2020-03-01)

Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
by: Yi-Ting Lin, et al.
Published: (2021-01-01)

Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis
by: Karamali Kasiri, Associate, et al.
Published: (2023-01-01)

Indication of acid suppression therapy and predictors for the prophylactic use of proton-pump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital
by: Oh AL, et al.
Published: (2015-09-01)

Prediction of Ventilator-Associated Pneumonia in Patients Undergoing Stress Ulcer Prophylaxis: A Longitudinal Descriptive Study in Iran
by: Shahriar Nikpour, et al.
Published: (2020-11-01)

A systematic review with meta‐analysis: Efficacy and safety of potassium‐competitive acid blocker compared with proton pump inhibitor in the maintenance of healed erosive esophagitis
by: Daniel M Simadibrata, et al.
Published: (2024-03-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
by: Mun Young Cho, et al.
Published: (2023-09-01)

Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients
by: Chien-Huei Huang, et al.
Published: (2024-01-01)

Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study
by: Yue Zhou, et al.
Published: (2021-05-01)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
by: Yu‐Tse Chiu, et al.
Published: (2023-02-01)

Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
by: Yi-Chun Chen, et al.
Published: (2022-09-01)

Effects of Gastric Acid Secretion Inhibitors for Ventilator-Associated Pneumonia
by: Fang Li, et al.
Published: (2022-05-01)

Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study
by: Chia-Jung Kuo, et al.
Published: (2021-10-01)

JP‐1366: A novel and potent potassium‐competitive acid blocker that is effective in the treatment of acid‐related diseases
by: Jin Mo Ku, et al.
Published: (2023-06-01)

Algorithm for pharmacists from community pharmacies who dispense over-the-counter proton pump inhibitors and histamine receptor antagonists for patients reporting symptoms of reflux
by: Elżbieta Jaworska, et al.
Published: (2024-01-01)

Efficacy comparison of 7- and 14-day P-CAB based bismuth-containing quadruple regimen with PPI based bismuth-containing quadruple regimen for Helicobacter pylori infection: rationale and design of an open-label, multicenter, randomized controlled trial
by: Chang Kyo Oh, et al.
Published: (2023-12-01)

The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research
by: Zhu LL, et al.
Published: (2016-06-01)

The effect of proton-pump inhibitors on development of arrhythmia and hypomagnesaemia after off-pump coronary artery bypass surgery
by: Hasan Abbaspour, et al.
Published: (2024-12-01)

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis
by: Biswas Sangita, et al.
Published: (2012-06-01)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
by: Xin Jiang, et al.
Published: (2019-09-01)

Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients
by: Juntao Xie, et al.
Published: (2022-07-01)

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients
by: Juntao Xie, et al.
Published: (2022-07-01)

The combined use of anti-peptic agents is associated with an increased risk of osteoporotic fracture: a nationwide case-control study
by: Dong Jun Oh, et al.
Published: (2024-03-01)

HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT
by: Schlioma ZATERKA, et al.

Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil
by: Helena Maciel-Guerra, et al.
Published: (2018-03-01)

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
by: Mijeong Son, et al.
Published: (2022-05-01)

Treatment strategies for reflux esophagitis including a potassium‐competitive acid blocker: A cost‐effectiveness analysis in Japan
by: Yasuki Habu, et al.
Published: (2021-09-01)

The Potential Benefits of Vonoprazan as <i>Helicobacter pylori</i> Infection Therapy
by: Muhammad Miftahussurur, et al.
Published: (2020-09-01)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
by: Xiaoyang Zhou, et al.
Published: (2019-11-01)

Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants
by: Man Yang, et al.
Published: (2022-01-01)

Which impact for proton pump inhibitors in SARS-COV-2 pneumonia
by: Grazia Mazzeo, et al.
Published: (2021-10-01)

Risk of urinary stone formation associated to proton pump inhibitors: A systematic review and metanalysis
by: Rawa Bapir, et al.
Published: (2022-12-01)